ERYTECH Pharma completes the enrollment of patients in its Phase I clinical trial in pancreatic cancer

  • Auteur/autrice de la publication :
  • Post category:Newsroom

ERYTECH Pharma has just completed the enrollment of patients in a Phase I clinical trial with its flagship product for pancreatic cancer, Graspa®.

Menu